• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis.

作者信息

Zonder Jeffrey A, Barlogie Bart, Durie Brian G M, McCoy Jason, Crowley John, Hussein Mohamad A

出版信息

Blood. 2006 Jul 1;108(1):403; author reply 404. doi: 10.1182/blood-2006-01-0154.

DOI:10.1182/blood-2006-01-0154
PMID:16790586
Abstract
摘要

相似文献

1
Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis.接受来那度胺和地塞米松治疗的新诊断多发性骨髓瘤患者的血栓并发症：阿司匹林预防的益处
Blood. 2006 Jul 1;108(1):403; author reply 404. doi: 10.1182/blood-2006-01-0154.
2
Aspirin as thromboprophylaxis in myeloma.阿司匹林用于骨髓瘤的血栓预防
Leuk Lymphoma. 2008 Aug;49(8):1646-7. doi: 10.1080/10428190802199978.
3
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.骨髓瘤中沙利度胺和来那度胺相关血栓形成的预防
Leukemia. 2008 Feb;22(2):414-23. doi: 10.1038/sj.leu.2405062. Epub 2007 Dec 20.
4
Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.预防性低剂量阿司匹林是沙利度胺或来那度胺联合治疗骨髓瘤的有效抗血栓形成疗法。
Leuk Lymphoma. 2007 Dec;48(12):2330-7. doi: 10.1080/10428190701647887.
5
Thrombosis in multiple myeloma (MM).多发性骨髓瘤（MM）中的血栓形成。
Hematology. 2012 Apr;17 Suppl 1(0 1):S177-80. doi: 10.1179/102453312X13336169156933.
6
Update of thrombosis in multiple myeloma.多发性骨髓瘤血栓形成的最新进展。
Thromb Res. 2016 Apr;140 Suppl 1:S76-80. doi: 10.1016/S0049-3848(16)30103-7.
7
Tailored thromboprophylaxis for patients with multiple myeloma treated by IMIDs.针对接受免疫调节药物治疗的多发性骨髓瘤患者的个体化血栓预防措施。
Leuk Lymphoma. 2008 Aug;49(8):1644-5. doi: 10.1080/10428190802187155.
8
Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.来那度胺和地塞米松治疗复发多发性骨髓瘤患者时，低分子量肝素对血栓栓塞并发症的有效预防作用
Ann Hematol. 2009 Jan;88(1):67-71. doi: 10.1007/s00277-008-0561-1. Epub 2008 Jul 31.
9
Thalidomide in front line treatment in multiple myeloma: serious risk of venous thromboembolism and evidence for thromboprophylaxis.沙利度胺用于多发性骨髓瘤的一线治疗：静脉血栓栓塞的严重风险及血栓预防证据
J Thromb Haemost. 2004 Nov;2(11):2063-5. doi: 10.1111/j.1538-7836.2004.00931.x.
10
Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review.来那度胺治疗的多发性骨髓瘤患者的血栓预防——一项系统评价
Thromb Res. 2016 May;141:84-90. doi: 10.1016/j.thromres.2016.03.006. Epub 2016 Mar 5.

引用本文的文献

1
Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapy.诱导治疗后新诊断的多发性骨髓瘤患者全自动凝血酶生成显著减弱。
J Thromb Thrombolysis. 2025 Mar;58(3):467-480. doi: 10.1007/s11239-025-03079-1. Epub 2025 Mar 10.
2
Arrhythmic Risk Stratification in Cardiac Amyloidosis: A Review of the Current Literature.心脏淀粉样变性中的心律失常风险分层：当前文献综述
J Cardiovasc Dev Dis. 2024 Jul 14;11(7):222. doi: 10.3390/jcdd11070222.
3
Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an expert panel.
多发性骨髓瘤中的血栓形成：风险分层、抗血栓预防和急性事件的处理。来自专家小组的基于共识的立场文件。
Haematologica. 2022 Nov 1;107(11):2536-2547. doi: 10.3324/haematol.2022.280893.
4
Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review.来那度胺、硼替佐米和地塞米松诱导疗法治疗新诊断多发性骨髓瘤：实用综述。
Br J Haematol. 2022 Oct;199(2):190-204. doi: 10.1111/bjh.18295. Epub 2022 Jul 7.
5
Assessing the risk of thromboembolism in cancer patients receiving immunotherapy.评估接受免疫治疗的癌症患者发生血栓栓塞的风险。
Eur J Haematol. 2022 Apr;108(4):271-277. doi: 10.1111/ejh.13734. Epub 2022 Jan 13.
6
Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms.抗癌治疗引起的心房颤动：电生理学及相关机制
Front Pharmacol. 2018 Oct 16;9:1058. doi: 10.3389/fphar.2018.01058. eCollection 2018.
7
Cardiovascular Complications of Multiple Myeloma Treatment: Evaluation, Management, and Prevention.多发性骨髓瘤治疗的心血管并发症：评估、管理与预防
Curr Treat Options Cardiovasc Med. 2018 Mar 6;20(3):19. doi: 10.1007/s11936-018-0618-y.
8
Spectrum of Cerebrovascular Disease in Patients with Multiple Myeloma Undergoing Chemotherapy-Results of a Case Control Study.接受化疗的多发性骨髓瘤患者的脑血管疾病谱——一项病例对照研究的结果
PLoS One. 2016 Nov 30;11(11):e0166627. doi: 10.1371/journal.pone.0166627. eCollection 2016.
9
Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants.癌症相关静脉血栓栓塞症：新型抗凝药物时代的治疗与预防更新。
Front Cardiovasc Med. 2016 Jul 28;3:24. doi: 10.3389/fcvm.2016.00024. eCollection 2016.
10
Safety and efficacy of primary thromboprophylaxis in cancer patients.癌症患者一级血栓预防的安全性与有效性。
Clin Transl Oncol. 2017 Jan;19(1):1-11. doi: 10.1007/s12094-016-1500-6. Epub 2016 May 4.